The Global Intravenous (IV) Injection Aseptic Packaging Market was valued at USD 8.79 Billion in 2023 and is projected to reach USD 12.57 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period (2024–2030). This sustained expansion is primarily driven by the rising global incidence of chronic diseases, an expanding volume of critical care and surgical procedures, and stringent regulatory demands for sterility and patient safety in pharmaceutical packaging.

As healthcare systems worldwide prioritize infection control and drug efficacy, the role of specialized aseptic packaging has become paramount. These packages—including vials, IV bags, and sterile barrier systems—ensure injectable drugs and biologics remain contaminant-free from manufacture to point of administration. In this blog, we profile the Top 10 Companies in the Intravenous Injection Aseptic Packaging Industry, highlighting the leading material scientists, glass specialists, and contract manufacturers who are setting the standards for safety, innovation, and reliability in this critical field.

---

🔟 1. Schott AG

Headquarters: Mainz, Germany
Key Offering: FIOLAX® & SCHOTT Vials, Syringes, Cartridges, Tubing Glass

SCHOTT is a global technology leader in specialty glass and is widely recognized as a premier supplier of pharmaceutical glass packaging. Its FIOLAX® borosilicate glass is the industry standard for vials and ampoules, offering superior chemical resistance and clarity. The company serves a vast majority of the world’s top pharmaceutical and biotech firms, providing packaging for vaccines, biologics, and high-value injectables.

Innovation & Industry Focus:

• Leading the transition to alternative primary packaging materials to reduce glass delamination risks
• Major investments in North American and Asian production capacity for vials and cartridges
• Pioneering eco-friendly, low-carbon glass manufacturing processes

Download FREE Sample Report:
Global Intravenous Injection Aseptic Packaging Market – View in Detailed Research Report

---

9️⃣ 2. Gerresheimer AG

Headquarters: Düsseldorf, Germany
Key Offering: Vials, Syringes, Cartridges, Inhalers, Plastic Ampoules

Gerresheimer is a leading global partner for the pharmaceutical and healthcare industries, offering a comprehensive portfolio of drug containment and delivery solutions. The company excels in both glass and plastic aseptic packaging, including its Gx^® RTF (Ready-to-Fill) plastic vials and syringes that are increasingly vital for sensitive biological drugs, reducing the need for terminal sterilization by end-users.

Innovation & Industry Focus:

• Strong focus on high-value, patient-centric delivery systems like auto-injectors and pen systems
• Global manufacturing footprint with Class A cleanroom facilities for integrated aseptic fill-finish services
• R&D in advanced polymer materials for enhanced drug stability and compatibility

---

8️⃣ 3. Amcor plc

Headquarters: Zurich, Switzerland
Key Offering: Flexible and Blow-Fill-Seal (BFS) Packaging, Medical Pouches, Lidding Films

Amcor, primarily known as a global leader in flexible and rigid plastic packaging, plays a crucial role in IV aseptic packaging through its medical and pharmaceutical division. Its expertise in Blow-Fill-Seal (BFS) technology is significant, producing sterile, unit-dose containers for respiratory therapy, ophthalmic solutions, and injectables without human intervention, offering a high-integrity barrier against contamination.

Innovation & Industry Focus:

• Development of high-barrier films and laminates for medical sterilization pouches and solution bags
• Sustainability focus with designs to reduce material use and increase recyclability
• Partnerships with medical device OEMs for integrated sterile barrier systems

---

7️⃣ 4. West Pharmaceutical Services, Inc.

Headquarters: Exton, Pennsylvania, USA
Key Offering: Stoppers & Seals, NovaPure® & Westar® Components, SmartDose® Wearable Injector

West Pharma is a cornerstone of the aseptic packaging ecosystem, supplying critical containment and delivery components. Its high-quality elastomeric closures (stoppers), seals, and aluminum caps are essential components for vial and syringe systems, ensuring sterility and container closure integrity (CCI). The company is deeply integrated into the fill-finish process of most major injectable drug manufacturers.

Innovation & Industry Focus:

• Leadership in CCI and extractables/leachables testing and standardization
• Expansion into drug delivery with advanced systems like the Daikyo Crystal Zenith® polymer syringe
• Strategic focus on high-growth biologics and complex injectable markets

Download FREE Sample Report:
Global Intravenous Injection Aseptic Packaging Market – View in Detailed Research Report

---

6️⃣ 5. Catalent, Inc.

Headquarters: Somerset, New Jersey, USA
Key Offering: Aseptic Fill-Finish, Blow-Fill-Seal, Vial & Syringe Packaging Services

Catalent is a dominant force in contract development and manufacturing (CDMO), offering extensive aseptic fill-finish capabilities. While not a primary packaging manufacturer, its role is pivotal as it packages billions of units of injectable drugs on behalf of pharma companies. Its global network of facilities provides vial, syringe, and cartridge filling, lyophilization, and secondary packaging under stringent aseptic conditions.

Innovation & Industry Focus:

• Industry-leading capacity for fill-finish of mRNA vaccines and other complex biologics
• Investment in high-speed syringe filling lines and automated visual inspection technologies
• End-to-end solutions from drug development through commercial aseptic packaging

---

5️⃣ 6. Becton, Dickinson and Company (BD Medical)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: BD Hypak™ Prefillable Syringes, BD Neopak™ Glass Syringes, Vials

BD Medical supplies a broad range of medical devices and is a key supplier of prefillable syringes (PFS) and delivery systems. Its BD Hypak™ glass PFS are a globally recognized platform for vaccines, biologics, and critical care drugs. The company provides comprehensive solutions that include the sterile syringe, passive safety features, and automated assembly technologies for drug manufacturers.

Innovation & Industry Focus:

• Strong emphasis on integration of safety-engineered devices into primary packaging
• Development of BD Neopak™ siliconized glass syringes for challenging drug formulations
• Focus on enabling self-administration and home healthcare through advanced delivery systems

---

4️⃣ 7. Stevanato Group

Headquarters: Piombino Dese, Italy
Key Offering: EZ-fill® Syringes, Alba® Glass, Vials, Cartridges, Integrated Fill-Finish Lines

The Stevanato Group provides integrated solutions for the containment and delivery of injectable drugs, with a strong legacy in high-quality glass and plastic primary packaging. Its EZ-fill® ready-to-use syringes and vials are designed to optimize filling line efficiency and reduce particulate risk. The company uniquely complements its packaging with high-value engineering services, including the design and manufacturing of inspection machines and assembly systems.

Innovation & Industry Focus:

• Vertically integrated from glass tubing production to final packaged drug delivery systems
• Significant investment in ready-to-use (RTU) solutions for the booming biologics market
• Expansion of its SG EZ-fill® Nexus platform combining containment, delivery, and diagnostic solutions

---

3️⃣ 8. SiO2 Materials Science

Headquarters: Auburn, Alabama, USA
Key Offering: Advanced Barrier Plastic Vials & Cartridges

SiO2 Materials Science is an innovator pioneering a paradigm shift from traditional glass. Its product is a plastic vial coated with an ultra-thin, pure glass layer (silicon dioxide), creating a container that is shatterproof like plastic but has the superior barrier properties of glass. This addresses critical issues like breakage, delamination, and silicone oil interactions, which is crucial for next-generation cell and gene therapies and sensitive biologics.

Innovation & Industry Focus:

• Leading the charge on alternative primary packaging to overcome limitations of borosilicate glass
• Strategic partnerships with major pharmaceutical companies for development and supply
• Focus on enabling the storage and shipment of ultra-cold chain (-80°C) therapies

---

2️⃣ 9. Ompi (Stevanato Group) / Nipro PharmaPackaging

Note: Ompi was fully integrated into the Stevanato Group. For a distinct #9 entry, we feature Nipro PharmaPackaging International.

Headquarters: Mechelen, Belgium (Nipro PharmaPackaging)
Key Offering: Glass & Polymer Vials, Ampoules, Cartridges, Prefillable Syringes

Nipro PharmaPackaging is a major global player in primary pharmaceutical glass and polymer packaging. As part of the Japanese Nipro Corporation, it offers a wide range of containers for injectable drugs, including its high-quality Valor® glass and innovative ClearJect® prefillable polymer syringes. The company has a strong presence in generics and biosimilar markets, providing reliable, cost-effective aseptic packaging solutions.

Innovation & Industry Focus:

• Significant capacity in tubular glass vials and ampoules with a global manufacturing base
• Development of advanced polymer solutions for drug-device combination products
• Focus on sustainable manufacturing and supply chain resilience

---

1️⃣ 10. Baxter (Hillrom) – Renray Healthcare / Oliver Healthcare Packaging

Note: The sterilization bag/pouch segment is vital. Oliver-Tolas (as mentioned in source data) is a key leader. For clarity, we focus on Oliver Healthcare Packaging.

Headquarters: Oak Brook, Illinois, USA (Oliver)
Key Offering: Sterilization Pouches, Lidding, Wrappers, Tyvek®/Paper/Plastic combinations

Oliver Healthcare Packaging specializes in medical-grade flexible packaging used for the final sterile barrier of packaged medical devices, including many IV administration sets and components. Their products, such as peel-open pouches and lidding materials, are critical for maintaining sterility after terminal sterilization (e.g., ethylene oxide, gamma irradiation) and during transportation to the hospital point of use.

Innovation & Industry Focus:

• Expertise in material science for breathable and non-breathable sterilization films
• Providing packaging validation services to meet ASTM and ISO 11607 standards
• Focus on sustainability with recyclable material options and reduction of packaging footprint

Get Full Report Here:
Global Intravenous Injection Aseptic Packaging Market – View in Detailed Research Report

---

🌍 Outlook: The Future of IV Aseptic Packaging is Smarter, Safer, and More Sustainable

The intravenous aseptic packaging market is undergoing a profound transformation. Driven by scientific advancement and regulatory rigor, the industry is moving beyond passive containers to intelligent, integrated systems that guarantee drug integrity from factory to vein.

📈 Key Trends Shaping the Market:

• Rise of Biologics and ATMPs: Cell, gene, and mRNA therapies demand ultra-high barrier, low-interaction containers, fueling growth for coated plastics (like SiO2) and advanced cyclic olefin polymers (COP/COC).
• Ready-to-Use (RTU) Revolution: To reduce contamination risk and manufacturing complexity, drugmakers are overwhelmingly adopting pre-sterilized, ready-to-fill vials, syringes, and cartridges, a major growth driver for suppliers like SCHOTT, Gerresheimer, and Stevanato.
• Supply Chain Resilience: Post-pandemic, geographic diversification of manufacturing capacity (especially in Asia-Pacific) and dual-sourcing strategies are paramount for pharmaceutical companies.
• Sustainability Mandates: Pressure is mounting to reduce the carbon footprint of glass production, increase use of recyclable materials in secondary/tertiary packaging, and develop closed-loop systems for high-value components.

Get Full Report Here:
Global Intravenous Injection Aseptic Packaging Market – View in Detailed Research Report

The companies profiled above are not merely suppliers of containers—they are essential partners in global health, providing the foundational technology that ensures life-saving injectable medicines reach patients safely, effectively, and reliably.